~~<i id='A2139C44DF'><strike id='A2139C44DF'><tt id='A2139C44DF'><pre id='A2139C44DF'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

fashion

author：explore 2025-08-31 01:57:08 - browse：43

It is one of health care’s most vexing quandaries: Patient data must be shared to develop more effective medicines and artificial intelligence tools, but there’s no way to share it without violating privacy and basic data rights.

Or is there?

A fresh crop of companies is building a new data economy that enables the shared use of personal health information while enforcing ironclad privacy protections. They are not a monolithic group: each one uses its own methods and technologies, serves different customers, and is motivated by distinct problems and personal philosophies.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： The surgeon had a dilemma only a Nazi medical text could resolve

Wikipedia

entertainment

hotspot

entertainment

hotspot

entertainment

AdobePharmacistsincreasinglyarebeingaskedtomakedrugsinbulkforhospitalsthatareinshortsupply,andthey’r

WSS

Beam Therapeutics to lay off 20% of its staff, re

New brain studies show LSD's effects on the brain in full color

How digital therapeutics firms are pivoting after Pear's bankruptcy

NIH confirmation hearing shows politicization of research

STAT Summit: GSK CEO on pharma giant's new direction

Parkinson’s finding may lead to tests and, someday, treatments

explore

fashion

Wikipedia

Duchenne breakthrough therapy leaves behind pioneering families

eGenesis tests gene

Medical records are filled with copy

HHS leader on health, climate change and biopharma emissions

Cancer drug shortages should be causing more outrage

STAT Summit: How a Chicago ER doctor tackles gun violence

Trump demands the U.S. pay no more for drugs than other countries … again

Beam Therapeutics to lay off 20% of its staff, re

Moonlake's readout produced a cash windfall. Risks remain

Test for long Covid? Researchers find new clue in blood samples

entertainment

First Opinion Podcast: Long Covid needs a new approach

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

EU regulator recommends expanding Mounjaro approval to obesity

STAT Summit: How a Chicago ER doctor tackles gun violence

Beam Therapeutics to lay off 20% of its staff, re

Beam Therapeutics to lay off 20% of its staff, re

hotspot

entertainment

hotspot

entertainment